Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Perampanel Oral Suspension vs Tablet
NCT02279485Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2014
- Primary completion
- Dec 2014
- Modality
- Classical Binding Small Molecules
01
Overview
Phase 1, randomised, open-label trial of perampanel in epilepsy (2 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Area Under the Concentration-Time Curve From Zero to Time t, Area Under the Concentration-Time Curve From Zero to Infinity and 1 more. Started Sep 2014; status: completed.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02279485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279485.